期刊文献+

两种肿瘤全身热疗方案的比较 被引量:3

The Comparison of Two Treatment Projects of Whole Body Hyperthermia
下载PDF
导出
摘要 本文针对全身热疗的两种治疗方案进行了回顾与分析,认为机体可以长时间耐受41.8℃的全身热疗而无明显的毒性反应,肿瘤细胞热杀伤效果肯定,是被广泛接受的治疗温度。而近年来有学者尝试低热(40℃~41.5℃)长时间全身热疗,治疗时间可达4小时~5小时,不需要麻醉,更像是发热;或可省却气管插管全身麻醉和减少治疗费用,而疗效不减。 The two treatment projects of whole body hyperthermia(WBH) were reviewed and analyzed. The treatment temperature of 41.8 ℃ was widely received since at the temperature the effect of heat killing and wounding of the tumor cell is distinct, the body can endure the heat for a long time and without obvious toxicity. Recently the other project of WBH, i.e. low temperature and long duration, was studied. The time was prolonged to 4 h~5 h without anaesthesia. Or omit general anaesthesia trachea intubatton and reduce the cost of treatment, and that curative effct don't reduce.
出处 《中国医学物理学杂志》 CSCD 2004年第3期150-152,共3页 Chinese Journal of Medical Physics
关键词 全身热疗 方案 治疗 whole body hyperthermia project treatment
  • 相关文献

参考文献17

  • 1林世寅 李瑞英.现代肿瘤热疗学[M].北京:学苑出版社,1996.70-71.
  • 2Wust P, Rau B, Gellerman J, et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer [J]. Recent Results CancerRes, 1998,146:175~191.
  • 3Rietbroek RC, van de Vaart PJ, Haveman J, et al. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells[J]. J Cancer Res Clin Oncol, 1997,123(1):6~12.
  • 4吴珊,刘宗石,chan jyh,吴秉铨.端粒酶活性热耐受程度的观察[J].中华病理学杂志,1999,28(5):382-383. 被引量:1
  • 5胡永成.全身热疗对免疫功能的影响[J].国外医学(肿瘤学分册),1995,22(2):92-96. 被引量:6
  • 6Westermann AM, Grosen EA, Katschinski DM, et al. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer[J]. Eur J Cancer, 2001,37(9):1111~1117.
  • 7Wiedemann GJ, Robins HI, Gutsche S, et al. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma [J]. Eur J Cancer, 1996,32A(5):888~892.
  • 8Wehner H, von Ardenne A, Kaltofen S. Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences[J]. Int J Hyperthermia, 2001,17(1):19~30.
  • 9Burd R, Dziedzic TS, Xu Y, et al. Tumor cell apoptosis, lymphoyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia[J].J Cell Physiol, 1998,177(1):137~147.
  • 10Wang XY, Ostberg JR, Repasky EA. Effect of fever-like wholebody hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation[J]. J Immunol, 1999,162(6):3378~3387.

二级参考文献6

  • 1吴珊,中华病理学杂志,1998年,27卷,91页
  • 2吴珊,中华医学杂志,1998年,78卷,515页
  • 3Yang S W,Proc Nat Acad Sci USA,1992年,89卷,2227页
  • 4Chan J Y,Nature,1987年,325卷,357页
  • 5Rong-Nian Shen,Ned B. Hornback,Homayoon Shidnia,Robert E. Shupe,Zacharie Brahmi. Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells[J] 1987,Journal of Clinical Immunology(3):246~253
  • 6Shuji Inoue,Susumu Ikehara,Takao Nakamura,Robert A. Good,Yoshihiro Hamashima. Two natural killer-cell subpopulations distinguished by heat sensitivity[J] 1985,Journal of Clinical Immunology(6):421~426

共引文献15

同被引文献26

  • 1王远东,周明,徐岗.非小细胞肺癌术后辅助全身热疗的疗效[J].广东医学,2006,27(2):204-205. 被引量:2
  • 2黎介寿.围手术营养支持的需要性[J].肠外与肠内营养,2006,13(3):129-131. 被引量:122
  • 3徐岗,王远东,周明.全身热化疗治疗晚期非小细胞肺癌临床研究[J].肿瘤研究与临床,2006,18(10):680-682. 被引量:7
  • 4王保庆,张世强,陈冬波,张兰胜,赵峰.去甲长春花碱联合顺铂与全身热疗治疗晚期非小细胞肺癌25例报告[J].华北煤炭医学院学报,2007,9(5):677-678. 被引量:1
  • 5Fidias PM,Dakhil SR,Lyss AP,et al. Phase IE study of immedi-ate compared with delayed docetaxel after front - line therapy withgemcitabine plus carboplatin in advanced non - small - cell lungcancer[ J]. J Clin Oncol,2009 ,27 :591 -598.
  • 6Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance peme-trexed plus best supportive care versus placebo plus best support-ive care for non - small - cell lung cancer: A randomized double-blind,phase 3 study[ J]. Lancet,2009,374 : 1432 - 1440.
  • 7Cappuzzo F, Ciuleanu T, Stelmakh L, et al. Erlotinib as mainte-nance treatment in advanced non - small - cell lung cancer : Amulticenter,randomized,placebo - controlled phase 3 study [ J].Lancet Oncol,2010,11:521 -529.
  • 8Perol M, Chouaid C, Milleron BJ,et al. Maintenance with eithergemcitabine or erlotinib versus observation with predefined secon-line treantment after cisplatind - gemcitabine induction chemo-therapy in advanced NSCLC : IFCT - GFPC 0502 phase HI study[J]. J Clin Oncol, 2010,28 (suppl) :540s.
  • 9L Zhang, M Shenglin, X Song, et al. Efficacy, tolerability, and bio-markeranalyses from a phase HI,randomized,placebo - con-trolled ,paralled group study of gefitinib as maintenance therapy inpatients with locally advanced or metastatic non - small - cell lungcancer[ J]. J Clin Oncol,2011 ,29( suppl) :7511.
  • 10Raut CP,Evans DB, Crane CH, et al. Neoadjuvant therapy for is- pectable pancreatic cancer[ J]. Surg Oncol Clin North Am,2004, 13(4) :639 -661.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部